Skip to main navigation
Skip to search
Skip to main content
The Catholic University of Korea Home
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth
Dong Joon Kim
, Yan Li
, Kanamata Reddy
, Mee Hyun Lee
, Myoung Ok Kim
,
Yong Yeon Cho
, Sung Young Lee
, Jong Eun Kim
, Ann M. Bode
, Zigang Dong
Pharmacy
Songsim Campus
University of Minnesota Twin Cities
Kyungpook National University
Research output
:
Contribution to journal
›
Article
›
peer-review
104
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Growth
100%
Colon Cancer
100%
In Vitro
75%
Phosphotransferase
75%
Programmed Cell Death
50%
Neoplasm
25%
Protein P53
25%
Colorectal Cancer
25%
Poly ADP Ribose Polymerase
25%
Cancer Cell
25%
Tumor Progression
25%
Anchorage
25%
Serine
25%
Mitogen Activated Protein Kinase 3
25%
Tumor Xenograft
25%
Caspase 7
25%
Mitogen Activated Protein Kinase Kinase
25%
Protein Kinases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
100%
Colon Cancer
100%
Phosphotransferase
100%
Colorectal Cancer
25%
Tumor Growth
25%
Protein P53
25%
Caspase 7
25%
Mitogen Activated Protein Kinase 3
25%
Mitogen Activated Protein Kinase Kinase
25%
Neoplasm
25%
Inflammation
25%
Protein Kinases
25%
Threonine
25%
Serine
25%
Immunology and Microbiology
Colon
100%
Cancer Cell
50%
Xenograft
25%
Mitogen
25%
Caspase
25%
Cell Growth
25%
P53
25%